STONEBRIDGE CAPITAL MANAGEMENT INC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
STONEBRIDGE CAPITAL MANAGEMENT INC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2014$262,000
-52.9%
24,685
-47.4%
0.10%
-51.9%
Q2 2014$556,000
+42.9%
46,900
+79.8%
0.21%
+30.4%
Q1 2014$389,000
+19.7%
26,090
+17.8%
0.16%
+22.9%
Q4 2013$325,000
-3.3%
22,150
+12.2%
0.13%
-13.8%
Q3 2013$336,000
+74.1%
19,750
+69.9%
0.15%
+68.9%
Q2 2013$193,00011,6250.09%
Other shareholders
IMMUNOGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders